Pre-bolusing is back

In a report entitled, Optimal prandial timing of bolus insulin in diabetes management: a review, looked at data from several studies and concluded that taking

Read More »

Faster insulin, soon

Faster insulin The Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA), has recommended marketing authorisation for Novo Nordisk Fiasp

Read More »

Metformin and gene variants

Researchers in an international study have uncovered new genetic evidence of how the benefits of the world’s most commonly used Type 2 diabetes drug may

Read More »

New insulin approved by FDA

Novo Nordisk has announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the US Food and Drug Administration (FDA) voted 16-0, recommending the

Read More »

Oral insulin pill possible

As reported by Reuters, tiny Israeli drugmaker Oramed Pharmaceuticals Inc on Wednesday said its experimental oral insulin succeeded in significantly reducing night-time blood glucose in

Read More »